Inhibition of CBS significantly reduced the growth rate of the tumor xenografts, which might be related to intratumoral mechanisms or paracrine mechanisms in the tumor microenvironment (Hellmich and Szabo, 2015). The gene discussed is CBS; the disease is neoplasm.